Immunovant, Inc.
IMVTHealthcareNASDAQBiotechnology · Last scanned Sep 8, 2026
Scan Results
Daily timeframePart of the healthcare sector, Immunovant, Inc. (IMVT) is listed under Biotechnology. Valued at $8.11B, IMVT is a mid-cap name in its sector. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy.
Market Cap
$8.11B
Beta
0.81
P/E (TTM)
—
P/E (Fwd)
-14.27
EPS (TTM)
$-2.81
EPS (Fwd)
$-2.75
ROE
-80.1%
ROA
-46.7%
Cash
$797.8M
Total Debt
$0
Free CF
-$238.7M
52W Change
139.3%
Annual Financials
Cash vs Debt
Where IMVT stands vs its 150-day and 200-day moving averages
As of the September 2, 2026 close, IMVT finished 24.38% above its 150-day moving average ($32.08) and 31.60% above its 200-day moving average ($30.32). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is IMVT overbought or oversold?
At the September 2, 2026 close, IMVT's RSI(14) was 36.7, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Immunovant, Inc. reports $797.8M in cash and $0 in total debt. Free cash flow is running at -$238.7M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. Return on equity stands at -80.1%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits.
Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. No single metric tells the full story. Reviewing IMVT's risk profile alongside its fundamentals and technical indicators provides a more complete picture.